Clinical Trial Update: Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on reducing the clinical target volume for early-stage nasopharyngeal carcinoma using intensity-modulated radiation therapy; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Target Volume Delineation, Early-stage Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED